Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany

MLA

Nathalie Largeron, et al. “Cost-Effectiveness of a Tetravalent Human Papillomavirus Vaccine in Germany.” Journal of Public Health, vol. 17, Oct. 2008, pp. 77–86. EBSCOhost, https://doi.org/10.1007/s10389-008-0228-3.

APA

Nathalie Largeron, K. Busch, Ruth McAllister, Karl Ulrich Petry, Peter Hillemanns, & Keith Tolley. (2008). Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany. Journal of Public Health, 17, 77–86. https://doi.org/10.1007/s10389-008-0228-3

Chicago

Nathalie Largeron, K. Busch, Ruth McAllister, Karl Ulrich Petry, Peter Hillemanns, and Keith Tolley. 2008. “Cost-Effectiveness of a Tetravalent Human Papillomavirus Vaccine in Germany.” Journal of Public Health 17 (October): 77–86. doi:10.1007/s10389-008-0228-3.